Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

#233;sartan /amlodipine 40/10 mg qui a réduit la pression artérielle centrale de manière significativement plus importante. Plus la baisse de la pression artérielle est importante, plus le risque d'événements cardiovasculaires pourrait être faible," a commenté le Professeur Luis Ruilope, investigateur principal de l'étude SEVITENSION.

NOTES AUX RÉDACTEURS

A propos de Sevikar®

Sevikar® est une association fixe d'olmésartan et amlodipine :[10]

  • L'olmésartan est un antagoniste des récepteurs de l'angiotensine II (ARA II) qui agit en empêchant l'action de l'angiotensine II. L'angiotensine II provoque une vasoconstriction et entraîne la production d'aldostérone, une autre hormone qui stimule la rétention d'eau dans l'organisme. En bloquant l'action de l'angiotensine II, l'olmésartan dilate les vaisseaux sanguins et réduit le volume de liquide circulant dans le sang, faisant ainsi baisser la pression artérielle. L'amlodipine est un inhibiteur calcique à longue durée d'action indiqué pour réduire la pression artérielle. L'amlodipine agit en relâchant les muscles lisses de la paroi des artères, provoquant ainsi une diminution de la résistance périphérique totale et par conséquent une baisse de la pression artérielle.

En plus d'une action puissante sur la baisse de la pression artérielle, l'association Olmesartan et Amlodipine offre un mode d'administration pratique avec une seule prise par jour d'un comprimé, permettant à la majorité des patients d'atteindre leur objectif de pression artérielle.

A propos des associations thérapeutiques (d'après les recommandations européennes sur la prise en charge de l'hypertensio
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Patent Offering, The patent’s technology ... or therapeutic imaging within a body lumen (open space). ... having a low cost, single-use disposable illumination and camera ... October 18, 2013 and the patent approval was received ... physician to customize the lighting and magnification of the ...
(Date:5/21/2015)... Ontario (PRWEB) May 21, 2015 ... into an exclusive North American distribution agreement with ... testing system. , With more than 160 years ... products and services for laboratory and production facilities, ... operational excellence and differentiated services to enable science. ...
(Date:5/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has ... Market Outlook 2020 " report to their offering. ... regenerative medicine is expected to have huge marketing potential. ... in the growth of deregulated organs. Several therapeutic molecules ... to form new tissue or sometimes organ transplant is ...
(Date:5/20/2015)... NEW YORK , May 20, 2015 /PRNewswire-USNewswire/ ... announced a leadership gift of $100 million from ... help create a new laboratory building that will ... campus extension. The Marie-Josée and Henry R. Kravis ... over the FDR Drive, spanning approximately three city ...
Breaking Biology Technology:IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4
... Inc., announced today that the organization has not ... 2010, Paul McDaniel became the interim President and ... operations are continuing and several employees who had ... Lisa P. Sumner, Esq., Poyner Spruill LLPAttorney for ...
... LifeVantage Corporation (OTC Bulletin Board: ... science-based therapy for oxidative stress, announced today that a ... scientific journal PLoS ONE.  The study, conducted by researchers ... underlie the ability of Protandim® to suppress tumors in ...
... Science, the innovative biological products and research services business ... announced the global release of a pioneering range of ... Sigma,s proprietary CompoZr zinc finger nuclease (ZFN) ... to offer innovative tools for drug discovery, compound screening ...
Cached Biology Technology:Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study 2Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study 3Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study 4Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study 5Sigma® Life Science Enters Genetically Modified Cell Market 2Sigma® Life Science Enters Genetically Modified Cell Market 3Sigma® Life Science Enters Genetically Modified Cell Market 4
(Date:5/8/2015)... SAN JOSE, Calif. , May 8, 2015 ... human interface solutions, today announced that members of the executive ... J.P. Morgan 43rd Annual Technology, Media and Telecom Conference ... Westin Waterfront Hotel in Boston, MA ... Date: May 27, 2015 Time: 2:45pm ET Location: The New ...
(Date:5/6/2015)... May 6, 2015 LifeBEAM, a developer of ... producer, announced today that they will expand their partnership ... first bio-sensing cycling helmet and the first joint project ... new colors in order to give cyclists more style ... addition, LifeBEAM and Lazer announced their plan to release ...
(Date:4/27/2015)... more than four decades, AUVSI,s Unmanned Systems ... event for the unmanned land, sea, and air industries. ... local, national, or trade news organization interested in gathering ... applications of unmanned technologies. The conference will explore the ... and how it will soon impact the lives of ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... helped boost green foliage across the world,s arid regions ... CO2 fertilisation, according to CSIRO research., In findings based ... National University (ANU), found that this CO2 fertilisation correlated ... from 1982-2010 across parts of the arid areas studied ...
... one of the major reasons why couples travel abroad ... regulations at home or raise concerns about financial inducement, ... Yet little is known about the women who provide ... their motivation and their compensation. A study performed ...
... study performed in Belgium has shown that low-cost ... feasible and effective, with delivery rates not much ... This proof-of-principle study, say the investigators, suggests that ... that the IVF methodology can be significantly simplified ...
Cached Biology News:Deserts 'greening' from rising CO2 2Egg donation in European clinics: Why do women do it? 2Egg donation in European clinics: Why do women do it? 3IVF for 200 euro per cycle 2IVF for 200 euro per cycle 3
Tissue-Stat ( Tissue Adherent for Mounting Formalin-Fixed and Frozen Tissue Sections.)...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Clarin Mounting Medium (Permanent environmentally safe mounting medium for general histology & cytology use)...
... Plus is formulated for covering tissue sections and ... soluble OR alcohol insoluble end products. ... as Fast Red or AEC that require an ... such as DAB. No heating is required prior ...
Biology Products: